Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV

This study has been completed.
Sponsor:
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00246402
First received: October 27, 2005
Last updated: May 14, 2014
Last verified: December 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2006
  Estimated Primary Completion Date: No date given
Publications: